← All companies

AbInitio Bio

Active

The Intelligence layer for Drug Manufacturing

P26·Spring 2026·Healthcare·San Francisco, CA, USA·Team of 1·Founded 2026

Website ↗YC page ↗LinkedIn ↗

Founders

Daniel Mukasa· Founder & CEO
Founder & CEO at AbInitio Bio (YC P26). Postdoctoral Fellow at MIT focused on AI and drug discovery. Previously AI/ML intern at Merck working on antibody therapeutic design. PhD in Applied Physics and Materials Science from Caltech.
LinkedIn ↗Twitter ↗

Change history · none recorded

◌

No changes recorded yet. Subsequent syncs will populate this timeline as fields drift.